ARCHIVES

Phase III Kyprolis Trial Fails OS Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 37 No. 8 | August 29, 2014

Download PDF Visit The Full Archive

Related Articles

Raub Corrects Record on ALERT

April 20, 1984

Women Surgeons: We Need Answers On Tamoxifin Now

May 13, 1994

“We Will Move Forward With Bold Expectations,” NCI Director Says

October 2, 1998

In Brief: Roper To Resign From CDC; Clinton Nominates Phillip Lee For Asst. Secretary For Health

March 19, 1993

Plans For NIH Women’s Health Study Discussed In Forum; $500 Mil. Program To Be Funded Through Contracts

November 8, 1991

PV-10 Produces 51 Percent Response Rate in Phase II Trial

October 26, 2012